Other group of transcripts regulated in response to NMDA antagonists contains genes involved in insulin-mediated cellular signaling pathway, including glucose transporter Slc2a1. The regulation of this pathway is potentially interesting in the context of connection between depression and insulin resistance in diabetic patients [30]. This evidence concerns the gene SLC2A1 and major depressive disorder.